Preclinical impact of high dose intermittent antiangiogenic tyrosine kinase inhibitor pazopanib in intrinsically resistant tumor models
Reguera-Nuñez, Elaine, Man, Shan, Xu, Ping, Kerbel, Robert S.Language:
english
Journal:
Angiogenesis
DOI:
10.1007/s10456-018-9623-8
Date:
May, 2018
File:
PDF, 1.41 MB
english, 2018